(Q38937549)

7 September 2017

title

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter (English)

1 reference

7 September 2017

12

Sarah C Gilbert

0 references

Ahmed M Salman

Ahmed M Salman

3

0 references

Alexandra Spencer

Alexandra J Spencer

2

0 references

Simon J. Draper

Simon J Draper

10

0 references

Teresa Lambe

Teresa Lambe

6

0 references

Adrian V. S. Hill

11

Adrian V S Hill

1 reference

7 September 2017

4

Claire M Tully

1 reference

7 September 2017

1

Naif Khalaf Alharbi

1 reference

7 September 2017

author name string

Senthil K Chinnakannan

5

1 reference

7 September 2017

Yuko Yamaguchi

7

1 reference

7 September 2017

Susan J Morris

8

1 reference

7 September 2017

Toritse Orubu

9

1 reference

7 September 2017

language of work or name

English

0 references

publication date

23 November 2015

1 reference

7 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

49-55

1 reference

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Poxvirus vectors as HIV/AIDS vaccines in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Clinical development of Modified Vaccinia virus Ankara vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Prime-boost vectored malaria vaccines: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Enhancing poxvirus vectors vaccine immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

A synthetic vaccinia virus promoter with enhanced early and late activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Vaccinia virus transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Dual neonate vaccine platform against HIV-1 and M. tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.028

10.1016/J.VACCINE.2015.11.028

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference